Taken together, the data demonstrated that inhibition of ROS/HMGB 1/RAGE/TLR4 pathway and HMGB 1-mediated activation of fibroblasts are, at least in part, responsible for the antifibrotic effect of resveratrol in DCM. The gene discussed is TLR4; the disease is familial dilated cardiomyopathy.